Indena S.P.A

  • Headquarter Milan
About Indena S.P.A

Indena is very well known as a leading API contract developer and supplier.
Funded in Italy in 1921, the company is privately owned and serving the global markets with its 4 manufacturing plants.

The technological offer covers APIs of botanical, fermentation and synthetic origin, with a unique expertise for HPAPIs. Capitalizing on its twenty year experience in handling HPAPIs development and manufacturing at large industrial scale, an additional new kilolab (LK2), designed to handle the production of highly toxic substances endowed with an OEL of 20 ng/m3 (including ...

Certifications
  • CE
    CE
  • FDA
    FDA
  • GMP
    GMP
  • ISO
    ISO
  • Other
  • IT
  • 2015
    On CPHI since
  • 5
    Certificates
  • 500 - 999
    Employees
Company types
CMO/CDMO
Manufacturer/Innovator
Pharmaceutical company
Primary activities
API Producer
Contract Manufacturer
Custom Manufacturing/Custom Synthesis
Nutraceuticals
Contact info
Meet us at

CPHI Frankfurt 2025

Messe, Frankfurt
28 Oct 2025 - 30 Oct 2025

Products from Indena S.P.A (42)

  • Cannabidiol (from hemp)

    Product Cannabidiol (from hemp)

    Natural cannabinoid from hemp
  • Colchicine Ph. Eur.

    Product Colchicine Ph. Eur.

    Colchicine ph. eur. Botanical origin: gloriosa superba l. seed. Biological activity: antigout.
  • Colchicine Usp

    Product Colchicine Usp

    Colchicine usp. Botanical origin: gloriosa superba l. seed. Biological activity: antigout. 
  • Docetaxel

    Product Docetaxel

    Indena SpA offers a wide range of pharmaceutical products which includes docetaxel. Botanical origin: taxus baccata l. twig and leaf. Biological activity: anti-mitotic, anticancer. 
  • Paclitaxel

    Product Paclitaxel

    Paclitaxel belongs to the group of taxanes together with Docetaxel. It is marked by a powerful anticancer activity. This natural product, found as part of a National Cancer Institute program in 1962 aiming at identifying natural active compounds to potentially treat cancer, is a cell division inhibitor...
  • Escin Extract

    Product Escin Extract

    Indena SpA offers a wide range of pharmaceutical products which includes escin extract. Botanical origin: aesculus hippocastanum l. seed. Biological activity: antioedema. Contact us for more information.
  • Escin Free Acid

    Product Escin Free Acid

    Indena SpA offers a wide range of pharmaceutical products which includes escin free acid. Botanical origin: aesculus hippocastanum l. seed. Biological activity: antioedema. Contact us for more information.
  • Escin Water Soluble

    Product Escin Water Soluble

    Indena SpA offers a wide range of pharmaceutical products which includes escin water soluble. Botanical origin: aesculus hippocastanum l. seed. Biological activity: antioedema. Contact us for more information.
  • Galanthamine Bromidrate

    Product Galanthamine Bromidrate

    Glanthamine bromidrate. Botanical origin: narcissus pseudonarcissus l. bulb. Biological activity: anti-alzheimer. 
  • Ginkgo Biloba Eur. Ph.

    Product Ginkgo Biloba Eur. Ph.

    Indena SpA offers a wide range of pharmaceutical products which includes ginkgo biloba eur. ph. Botanical origin: ginkgo biloba l. leaf. Biological activity: blood circulation improver. Contact us for more information.
  • Ginseng 27-30%

    Product Ginseng 27-30%

    Indena SpA offers a wide range of pharmaceutical products which includes ginseng 27-30%. Botanical origin: panax ginseng c.a. meyer root. Biological activity: adaptogen, tonic. Contact us for more information.
  • Horse Chestnut Extract

    Product Horse Chestnut Extract

    Indena SpA offers a wide range of pharmaceutical products which includes horse chestnut extract. Botanical origin: aesculus hippocastanum l. seed. Biological activity: antioedema, venotropic. Contact us for more information.

Indena S.P.A Resources (3)

  • Video From the Rainforest to the Clinic. Turning a High-Potency Rare Natural Product Into an Anticancer API

    Natural products can be characterized by complex structure, limited availability, and exceptional potency, whose combination makes it challenging their development as API. Success requires integration of expertise in different areas, including the construction of a sustainable supply chain for the starting biomass, the capacity to manipulate high-potency products in a GMP environment, and the versatility to strategically complement isolation with semi-synthesis, total synthesis and biotechnology. In this context, mutual thrust between the service provider company and the drug candidate owner is critical, and the successful development of the anticancer drug tigilanol tiglate will give the opportunity to address these issues.
  • Whitepaper CDMO services

    We have a unique expertise in developing and manufacturing HPAPIs. The company is equipped with kilolabs (for clinical and small commercial batches) and large industrial suite for HPAPIs with an OEL>20 ng/m3.